Evidence map›Paper›PMID 38441336›Full record

ArticleThe Journal of infectious diseases2024

Functional and Immunologic Mapping of Domains of the Reticulocyte-Binding Protein Plasmodium vivax PvRBP2a.

Matthew Zirui Tay, Weiyi Tang, Wenn-Chyau Lee, Alice Soh Meoy Ong, Wisna Novera, Benoît Malleret, Guillaume Carissimo, Ann-Marie Chacko, Abbas El-Sahili, Julien Lescar and 8 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 5 countries.

Matthew Zirui TayA*STAR Infectious Diseases Labs, Agency for Science, Technology and Research, Singapore.ORCID 0000-0002-1763-913X
Weiyi TangA*STAR Infectious Diseases Labs, Agency for Science, Technology and Research, Singapore.
Wenn-Chyau LeeA*STAR Infectious Diseases Labs, Agency for Science, Technology and Research, Singapore.
Alice Soh Meoy OngA*STAR Infectious Diseases Labs, Agency for Science, Technology and Research, Singapore.
Wisna NoveraLaboratory for Translational and Molecular Imaging, Cancer and Stem Cell Biology Programme, Duke-NUS Medical School.
Benoît MalleretDepartment of Microbiology and Immunology, Immunology Translational Research Programme.
Guillaume CarissimoA*STAR Infectious Diseases Labs, Agency for Science, Technology and Research, Singapore.
Ann-Marie ChackoLaboratory for Translational and Molecular Imaging, Cancer and Stem Cell Biology Programme, Duke-NUS Medical School.
Abbas El-SahiliNTU Institute for Structural Biology, Nanyang Technological University.
Julien LescarNTU Institute for Structural Biology, Nanyang Technological University.ORCID 0000-0002-9623-8130
Yiping FanDepartment of Reproductive Medicine, KK Women's and Children's Hospital.ORCID 0000-0002-6269-1519
Rose M McGreadyShoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand.
Cindy S ChuShoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand.
Jerry Kok Yen ChanDepartment of Reproductive Medicine, KK Women's and Children's Hospital.
Lisa F P NgA*STAR Infectious Diseases Labs, Agency for Science, Technology and Research, Singapore.
Bruce RussellDepartment of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.ORCID 0000-0003-2333-4348
François NostenShoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand.
Laurent RéniaA*STAR Infectious Diseases Labs, Agency for Science, Technology and Research, Singapore.ORCID 0000-0003-0349-1557
Agency for Science, Technology and Research · SGMahidol University · THNational University of Singapore · SGDuke-NUS Medical School · SGNanyang Technological University · SGUniversity of Otago · NZ

Funding

A*STAR to A*STAR Infectious Diseases LabsBiomedical Research CouncilImmunomonitoring Service Platform NRF2017_SISFP09Industry Alignment Fund Pre-positioning H18/01/a0/018Marsden Grant Award RGUOO180301Ministry of Education 022388-00001National Research FoundationNMRC STaR Investigator Award NMRC STaR22jul-0004Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol UniversitySingapore National Medical Research Council NMRC/OFIRG/0065/2018Singapore's Health and Biomedical SciencesStart-up University GrantTemasek Foundation Infectious Diseases Programme for Surveillance and Diseases X ResilienceThe Wellcome Trust of Great BritainWellcome Trust
6 · The paper itself

Abstract

We previously described a novel Plasmodium vivax invasion mechanism into human reticulocytes via the PvRBP2a-CD98 receptor-ligand pair. Using linear epitope mapping, we assessed the PvRBP2a epitopes involved in CD98 binding and recognized by antibodies from patients who were infected. We identified 2 epitope clusters mediating PvRBP2a-CD98 interaction. Cluster B (PvRBP2a431-448, TAALKEKGKLLANLYNKL) was the target of antibody responses in humans infected by P vivax. Peptides from each cluster were able to prevent live parasite invasion of human reticulocytes. These results provide new insights for development of a malaria blood-stage vaccine against P vivax.

Indexed as

Antibodies, ProtozoanEpitope MappingMalaria, VivaxPlasmodium vivaxProtozoan ProteinsReticulocytesAntigens, ProtozoanEpitopesHumansMalaria VaccinesMembrane ProteinsAntibodies, ProtozoanAntigens, ProtozoanEpitopesMalaria VaccinesMembrane ProteinsProtozoan Proteinsreticulocyte-binding protein, Plasmodium vivaxCD98invasionPlasmodium vivaxPVRBP2areticulocytes

Identifiers

PMID38441336
PMCPMC11420707
OpenAlexW4392460493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.